SS
NVCR icon

SBI Securities’s NovoCure NVCR Stock Holding History

SBI Securities’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22K Buy
2,015
+222
+12% +$2.77K ﹤0.01% 1417
2025
Q4 		$23.2K Buy
1,793
+168
+10% +$2.16K ﹤0.01% 1375
2025
Q3 		$21K Buy
1,625
+312
+24% +$4.17K ﹤0.01% 1430
2025
Q2 		$23.4K Buy
1,313
+84
+7% +$1.46K ﹤0.01% 1355
2025
Q1 		$21.9K Sell
1,229
-1,112
-48% -$25.3K ﹤0.01% 1297
2024
Q4 		$69.8K Buy
+2,341
New +$49.5K ﹤0.01% 873

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

SBI Securities's NVCR Position: Q1 2026 in Review

SBI Securities increased its NovoCure (NVCR) stake by 12% in Q1 2026, buying an estimated $2.77K and bringing the position to 2,015 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1417.

SBI Securities first reported a position in NVCR in Q4 2024 and has held it in 6 quarters since. The position peaked at $69.8K in Q4 2024. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • SBI Securities held 2,015 shares of NovoCure worth $22K as of Q1 2026.
  • SBI Securities bought 222 NovoCure shares in Q1 2026, an estimated $2.77K.
  • NovoCure made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1417 holding.
  • SBI Securities first reported a position in NovoCure in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's NovoCure position peaked at $69.8K in Q4 2024.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.